CBP-1018

CBP-1018 is a peptide-drug conjugate (PDC) composed of a dual-targeting ligand for FRα/TRPV6, linked to Monomethylauristatin E. It holds promise for research in the field of breast cancer.

[C@H]([C@H](C(N[C@@H]([C@@H](O)C1=CC=CC=C1)C)=O)C)(OC)[C@]2(N(C(C[C@H]([C@@H](N(C([C@@H](NC([C@@H](N(C(OCC3=CC=C(NC([C@@H](NC([C@@H](NC(CCCCCN4C(=O)C(SC[C@H](NC([C@@H](NC([C@@H](NC([C@@H](NC(CC5=CC=C(CNC(NCCCC[C@H](NC(N[C@@H](CCC(O)=O)C(O)=O)=O)C(O)=O)=O)C=C5)=O)CC(O)=O)=O)CC(O)=O)=O)CCCCN)=O)C(N[C@@H](CCCCNC(CC[C@H](NC(=O)C6=CC=C(NCC=7N=C8C(NC7)=NC(N)=NC8=O)C=C6)C(O)=O)=O)C(N)=O)=O)CC4=O)=O)[C@@H](C)C)=O)CCCNC(N)=O)=O)C=C3)=O)C)[C@H](C)C)=O)C(C)C)=O)C)[C@H](CC)C)OC)=O)CCC2)[H]